Results 111 to 120 of about 1,042,470 (180)

Vaccination contre la souche influenza PR8 à l'aide d'un vaccin recombinant SG33-M2e [PDF]

open access: yes, 2010
Cette étude présente un essai d’immunisation à l’aide d’un vaccin recombinant poxviral. Le processus de fabrication du vaccin est basé sur la fusion protéique entre l’antigène considéré et une protéine d’enveloppe du poxvirus.
Boyer, Guillaume
core  

Remodelling of P-bodies and the cytoskeleton by <i>Orthohantavirus puumalaense</i> (Puumala virus). [PDF]

open access: yesJ Gen Virol
Schwarzer-Sperber HS   +13 more
europepmc   +1 more source

Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection. [PDF]

open access: yesEBioMedicine
Clark JJ   +10 more
europepmc   +1 more source

Genetic analysis implicates ERAP1 and HLA as risk factors for severe Puumala virus infection. [PDF]

open access: yesHum Mol Genet
Haapaniemi H   +9 more
europepmc   +1 more source

Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection. [PDF]

open access: yesNPJ Vaccines
Hooper JW   +16 more
europepmc   +1 more source

Use of a diagnostic Puumala virus real-time RT-PCR in an orthohantavirus endemic region in the Netherlands. [PDF]

open access: yesMicrobiol Spectr
Geeraedts F   +9 more
europepmc   +1 more source

Spatial and temporal patterns of human Puumala virus (PUUV) infections in Germany. [PDF]

open access: yesPeerJ, 2018
Cunze S   +5 more
europepmc   +1 more source

Expansion of spatial and host range of Puumala virus in Sweden: an increasing threat for humans? [PDF]

open access: yesEpidemiol Infect, 2017
Borg O   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy